Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Inclusion Criteria: * Female between the age of 12 years and 13 years, inclusive. (Female 7th grade junior high school students in Indonesia) * Clinically healthy, as established by medical history and physical examination before entering the study. * Not pregnant at the time of vaccination. * Able to provide informed consent and assent. * Able to comply with the study. Exclusion Criteria: * Previous vaccination against HPV. * Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days prior to study enrollment, or planned use during the study period. * Administration of any vaccine within 30 days prior the study enrollment, or within 30 days of study vaccination visits. * Chronic administration of immunosuppressants or other immune-modifying drugs within six months prior to the study enrollment, or planned use during the study period. * Any medically diagnosed or suspected immunodeficient condition based on medical history and physical examination. * History of allergic disease, suspected allergy, or reactions likely to be exacerbated by any component of vaccine, including yeast. * History of chronic condition(s) requiring treatment such as cancer, chronic hepatitis or kidney disease(s), diabetes, autoimmune disease. Participants with medically stable, well controlled autoimmune disease may be permitted. * Thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection. * Received immunoglobulins and/or blood product within 90 days preceding enrollment, or planned use during the study period. * Acute disease at the time of enrollment. Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhea, mild upper respiratory infection with or without low-grade febrile illness, i.e., axillary temperature \<37.5°C. * Any condition that may interfere with ability to comply with trial procedures, as assessed by the Investigator.